The current option for the management of Intermediate-Level Waste (ILW) and High-Level Waste (HLW) in the UK is to store it in stainless steel containers and then placed in a deep underground Geological Disposal Facility (GDF). This may subsequently be backfilled with a cementitious material generating very high pH conditions. The eventual corrosion of the stainless steel canisters containing the waste used for disposal will lead to reducing conditions thereby promoting a low Eh environment. Electrochemical experiments are needed to determine which uranium species is/are present at a particular pH and to model the redox behaviour of aqueous uranium in a potential GDF. The main aim of this project is to use cyclic voltammetry to deduce peak potentials for the various uranium redox couples in aqueous solution across the pH range and in particular the hyperalkaline range, as the surroundings of a GDF will be in high pH conditions. Data in the literature have been obtained only under acidic conditions where they were subsequently extrapolated to obtain data for alkaline conditions in some reports. Is this valid however? Experiments are therefore needed to obtain fundamental data under alkaline conditions to fill in gaps in the literature. In addition to radionuclides, complexing organic ligands present in a cementitious repository could have an important effect on the immobilisation of radionuclides in concrete. This is due to the ability of the ligands to form complexes with cations, thereby enhancing their solubility and mobility in the cement pore water. Four different ligands were investigated in this project that are relevant to nuclear waste disposal which comprised of carbonate, ethylenediaminetetraacetic acid (EDTA), gluconic acid and α-isosaccharinic acid (α-ISA). The peak potentials of each uranium redox reaction in aqueous solution were measured and the potentials were compared in ligand and non-ligand systems. The voltammograms were compared to obtain their similarities and differences in terms of the shape of the cyclic voltammograms, peak potentials, reversibility, current responses and etc. Analysis of the similarities and differences was needed to be able to increase the understanding of the complexation effects of these ligands with uranium under different pH conditions in aqueous solution.

Long relegated to the background by the pre-eminence of magnesium-based, stoichiometric Grignard reagents, a distinct chemistry of the heavier alkaline earth metals, calcium, strontium and barium, is only now starting to emerge. As similarities have been drawn between the large, electropositive, redox-inert and d0 alkaline earth Ae2+ dications and the Ln3+ cations of the lanthanide series, a growing group 2-mediated catalytic chemistry has developed over the last decade, including polymerisation reactions, heterofunctionalisation reactions of multiple bonds and some rare examples of dehydrocoupling reactions. Among these catalytic reactions the magnesium- and calcium-catalysed intramolecular hydroamination of aminoalkenes has attracted particular interest. Mechanistic studies have demonstrated many parallels with the lanthanide-mediated catalytic cycle based upon successive σ-bond metathesis and insertion steps. In the first part of this thesis, further investigations into the hydroamination/cyclisation reaction have demonstrated the prominent role of the charge density of the catalytic group 2 cation (M = Mg, Ca, Sr, Ba), the beneficial influence of stabilising spectator ligands, and the importance of the choice of the reactive co-ligand for efficient catalyst initiation. Kinetic analyses of reactions monitored by NMR spectroscopy have given new insight into activation energies, entropic effects, substrate and product inhibition, and kinetic isotope effects, leading to a review of the previously suggested lanthanide-mimetic mechanism. In a second part, this study seeks to address two of the main challenges posed by the intramolecular hydroamination reaction in particular, and heavier alkaline earth-catalysed reactions in general: (i) The need to design new monoanionic spectator ligands capable of stabilising heteroleptic heavier alkaline earth complexes and preventing deleterious Schlenk-type ligand redistribution processes in solution; (ii) The stabilisation of highly reactive heteroleptic group 2 alkyl functionalities for fast, irreversible catalyst initiation and novel reactivity.

Phosphate transfer is ubiquitous in nature, however the occurance of phosphomutases is rare. Their uniqueness can be attributed to the complex and malleable substrate recognition scheme that allows the enzyme to perform two similar, yet distinct, catalytic steps while maintaining strict fidelity for substrate versus water. The complexity of developing this mechanism is highlighted in that, while phosphomutase function has independently evolved in most larger phosphotransferase superfamilies, very little diversification of this function has developed. As such, phosphomutases provide a rich framework to study the intricate specificity mechanisms employed by enzymes. β-Phosphoglucomutase (bPGM) catalyzes the interconversion between β-glucose 1-phosphate (βG1P) and glucose 6-phosphate (G6P) via a β-glucose 1,6 bisphosphate (βG16P) intermediate. βPGM is in one of two subfamilies that have independently acquired phosphomutase activity within the ubiquitous Haloalkanoate Dehalogenase superfamily (HADSF) of phosphotransferases. The enzyme has been observed to undergo a large conformational change upon binding βG16P as well as a repositioning of the general acid/base catalyst residue Asp10. In addition, the mechanism involves cycling of the protonation state of Asp10, which requires a significant pKa shift. The importance of Asp10 and its activation of the enzyme have been discussed previously, however a clear understanding of the interplay between the conformational and catalytic activation mechanisms for βPGM has not been described. This work uses aqueous phase techniques, solution X-ray scattering and molecular dynamics, to probe the effect of individual ligand moieties on the conformational state of the enzyme and free energy molecular dynamics and electrostatic calculations determine the interplay between conformation, protonation and Asp10 activation. The results implicate a model where the ligand-induced conformational change is governed by the non-catalytic phosphate site, and this transition induces correct positioning of Asp10, which, in turn induces the pKa shift, forming the catalytically competent complex.

In chapter 1, I discuss how ligand architecture in tripodal nitrogen-rich ligands can drastically affect the structure of zinc complexes featuring these ligands. The synthesis and characterization of zinc tris(1-methylimidazol-2-ylthio)methyl ([Titm^Me]) and tris(1-Pribenzimidazol-2-ylthio)methyl ([Titm^iPr,benzo]) complexes is presented. The ligand in [Titm^Me]Zn complexes binds the metal to form carbatrane structures that exhibit unusually long and flexible Zn–C bonds. The bonding between the zinc and the carbon in these complexes can therefore be more accurately described as a zwitterionic interaction between a carbanion and a zinc cation. Density functional theory calculations demonstrate that the energy profile for the Zn–C bond is shallow, such that large variations of the Zn–C distance result in very little change in the energy of the complex. The benzannulated ligand [Titm^iPr,benzo] allows access to a rare monomeric zinc hydride species [κ³-Titm^iPr,benzo]ZnH that can react with either CO₂ to produce a zinc formate, or B(C₆F₅)₃ to form the ion pair [κ⁴-Titm^iPr,benzo]ZnHB(C₆F₅)₃. The coordination chemistry of the [Titm^iPr,benzo] ligand also extends to the other metals of group 12. In chapter 2, I report the use of the [Titm^Me] and [Titm^iPr,benzo] zinc complexes presented in chapter 1 as biomimetic models for zinc enzymes. First, [Titm^Me] zinc complexes present structural similarities with the active site of carbonic anhydrase, and can be used to study the binding of carbonic anhydrase inhibitors to the enzyme active site. Then, [κ⁴-Titm^iPr,benzo]ZnX (X = MeB(C₆F₅)₃, BPh₄) complexes and their interactions with ligands of relevance towards antibiotic resistance is reported. The non coordinating nature of the anions in [κ⁴-Titm^iPr,benzo]ZnX (X = MeB(C₆F₅)₃, BPh₄) lead to the formation of a Lewis acidic zinc cationic center, which can be coordinated by an additional ligand of biological interest. The binding of simple β-lactams to the [κ⁴-Titm^iPr,benzo]ZnX complexes can be probed using X-ray diffraction and Nuclear Magnetic Resonance (NMR) spectroscopy, thereby providing a way to model the binding of antibiotics to the active site of the metallo-β-lactamases enzymes responsible for broad antibiotic resistance. The binding of β-lactams can be compared to larger ring size lactams and linear amides. [κ⁴-Titm^iPr,benzo]ZnX (X = MeB(C₆F₅)₃, BPh₄) also allows for the study of the binding of potential metallo-β-lactamases inhibitors, such as, for example, glycinamide, picolinamide, and piperazine-2,3-dione. Binding studies between [κ⁴-Titm^iPr,benzo]ZnX and substrates bearing structural similarities to antibiotics reveal secondary interactions involving peripheral functional groups the cationic zinc center in [κ⁴-Titm^iPr,benzo]ZnX. These studies provide guidelines to modify existing antibiotics, in order to decrease their sensitivity to metallo-β-lactamases. In chapter 3, I explore the reactivity of previously characterized tris(2-pyridylthio)methyl [Tptm] zinc complexes. First, an improved synthesis of [κ⁴-Tptm]ZnF using Me₃SnF as the fluorinating agent is reported. The fluorine atom in [κ⁴-Tptm]ZnF acts as a Lewis base, as illustrated by its reaction with B(C₆F₅)₃ to form [κ⁴-Tptm]ZnFB(C₆F₅)₃, in which the fluorine is transferred to the borane group. The fluoride ligand in [κ⁴-Tptm]ZnF also acts as a hydrogen bond and halogen bond acceptor and is capable of forming adducts with H₂O, indole, and iodopentafluorobenzene. [κ⁴-Tptm]ZnF undergoes metathesis with Ph₃CCl to form Ph₃CF, thereby providing a rare example of C–F bond formation promoted by a zinc complex. Then, [κ³-Tptm]ZnH is used as a catalyst for the hydrosilylation of aldehydes and ketones using phenylsilane to produce tris alkoxysilane products. The catalyst is very active with aldehydes, and shows slower reactivity towards dialkyl ketones. The reaction proceeds via insertion of the carbonyl group in the Zn–H bond to form a zinc alkoxide, which then undergoes metathesis with the silane to generate the desired product and regenerate the zinc hydride species. The complicated NMR spectroscopic features of the products resulting from the hydrosilylation of prochiral ketones are explained by the presence of different diastereomers. Finally, we report that [κ³-Tptm]ZnH is a catalyst for the hydrosilylation of silylformates to methoxy silanes with (EtO)₃SiH, (MeO)₃SiH and κ⁴-N(CH₂CH₂O)₃SiOMe. We show that CO₂ can be reduced to methoxy silane species in a one pot reaction using (MeO)₃SiH and catalytic amounts of [κ³-Tptm]ZnH. In chapter 4, I report the synthesis and characterization of a silicon based analogue of [Titm^iPr,benzo], namely the tris(1-Pribenzimidazol-2-yldimethylsilyl)methyl [Tism^iPr,benzo] ligand. The ligand possesses unique structural features, due to the proximity between the dimethylsilyl groups and the methyl carbanion. The formation of [κ⁴-Tism^iPr,benzo]Li proceeds via the doubly base stabilized silene intermediate [κ³-C(SiMe₂benzimid^iPr)₂]SiMe₂. [κ⁴-Tism^iPr,benzo]Li can be used as a precursor for copper and nickel [Tism^iPr,benzo] and [C₃-Tism^iPr,benzo] complexes, where [C3-Tism^iPr,benzo] represents the isomerized tris carbene version of [Tism^iPr,benzo]. [κ³-C(SiMe₂benzimid^iPr)₂]SiMe₂ reacts with ZnMe₂ to produce [κ³-C(SiMe₃)(SiMe₂benzimid^iPr)₂]ZnMe, which can be transformed to the phenoxide compound. This compound acts as a catalyst for the hydrosilylation of CO₂ to silyl formates and methoxy silanes. [κ³-C(SiMe₂benzimid^iPr)₂]SiMe₂ itself reacts with CO₂ to produce an unusual β-lactone.

P2X receptors (P2XRs) are trimeric cation channels activated by extracellular ATP. Human P2XRs (P2X1-7) are expressed in nearly all mammalian tissues, and they are an important drug target because of their involvement in inflammation and neuropathic pain. The aim of this thesis is to address the following questions. P2XR crystal structures have revealed an unusual U-shape conformation for bound ATP; how does the U-shape conformation of ATP and its derivatives affect channel activation? Where and how do the selective, non-competitive inhibitors AZ10606120 and A438079 bind to P2X7R? What is the structure of the hP2X1R intracellular domain in the closed state? Molecular modelling and bioinformatics were used to answer these questions, hypotheses resulting from this work were tested in collaboration with Prof. Evans. Investigating the binding modes of ATP and its deoxy forms in hP2X1R showed that the ribose 2′-hydroxyl group is stabilising the U-shape conformation by a hydrogen bond to the γ-phosphate. The reduced ability of 2′-deoxy ATP to adopt the U-shape conformation could explain its weak agonist action in contrast to full agonists ATP and 3′-deoxy ATP. Ligand docking of AZ10606120 and A438079 into the hP2X7R predicted an allosteric binding site, this site has meanwhile been confirmed by P2X7R/antagonist X-ray structures. MD simulations suggested that unique P2X7R regions (residues 73-79 and T90/T94) contribute to an increase of the allosteric pocket volume compared to the hP2X1R. This difference in size might be the key for selectivity. The hP2X1R intracellular domain in the closed state was modelled ab initio, and interpreted in context of chemical cross-links (collaboration with Prof. Evans). This suggests a symmetrical arrangement of two short b-antiparallel strands within the Nterminal region and short a-helix in the C-terminal region and additional asymmetrical states.

Os PPARs são fatores de transcrição ativados por ligantes, pertencentes à superfamília dos receptores nucleares, que são considerados sensores de lipídeos capazes de transformar alterações nos padrões de lipídeos/ácidos graxos dos organismos em atividade metabólica. Com isto, os 3 isotipos (α, δ e γ) estão associados a diferentes desordens metabólicas como doenças vasculares, diabetes, obesidade, câncer e certas doenças mentais que constituem um grave problema de saúde pública mundial, o que torna esta classe de proteínas, um valioso alvo para a indústria farmacêutica. Embora a importância do hPPARδ na regulação da transcrição de genes relacionados a uma série de processos metabólicos seja conhecida, não há ainda nenhum fármaco no mercado cujo alvo seja este receptor. O maior conhecimento a respeito da estrutura deste receptor pode trazer esclarecimentos capazes de auxiliar o desenvolvimento racional de fármacos. Desta forma, no presente trabalho, buscou-se encontrar características estruturais importantes para a seletividade e especificidade dos ligantes pelo isotipo δ. Para tal, determinou-se as condições de expressão e purificação da proteína hPPARδ LBD, bem como as condições apropriadas de manutenção da mesma por meio da técnica de dicroísmo circular. O estado oligomérico deste receptor foi determinado em solução através das técnicas de cromatografia por exclusão de tamanho e por espalhamento dinâmico de luz, onde se concluiu que a proteína é monomérica nas condições testadas. Além disto, através de uma estrutura de alta resolução da proteína hPPARδ LBD com o ligante GW 0742, propôs-se a construção de dois mutantes, V312M e I328M, através dos quais concluiu-se que estes dois resíduos são potencialmente importantes para interação de ligantes estruturalmente relacionados com GW 0742, ao isotipo δ, indicando dois determinantes relacionados à seletividade de ligantes por este isotipo. Como existem poucos relatos sobre a estrutura completa deste receptor, e consequentemente da influência que os domínios N-terminal e DBD apresentam sobre o domínio LBD, um breve estudo da interação diferencial entre o receptor nuclear hPPARδ Full e três diferentes cofatores, em presença de ligante agonista e antagonista foi realizado. Para isto, determinou-se as condições de expressão e purificação da proteína hPPARδ Full, e prosseguiu-se com ensaios de anisotropia de fluorescência, através dos quais ficou claro que cada cofator apresenta um padrão diferente de interação com a proteína que pode ser dependente de outras regiões da proteína além daquelas já classicamente descritas. Isto é um forte indicativo de que diferentes regiões do hPPARδ podem ser chave no processo de regulação por intermédio de cofatores. / PPARs are transcription factors activated by ligands, belonging to the superfamily of nuclear receptors, which are considered to be lipid sensors capable of making changes in patterns of lipid/fatty acid metabolic activity of organisms. The three isotypes (α, δ and γ) are associated with different metabolic disorders and vascular diseases as diabetes, obesity, cancer and certain mental illnesses which comprise a serious worldwide public health problem, making this class of proteins a valuable target for the pharmaceutical industry. Although it is known the importance of hPPARδ in regulating transcription of genes related to a series of metabolic processes, there is still no drug on the market directed to this receptor. Knowledge about the structure of this receptor can bring clarification able to assist the rational development of drugs. Therefore, in the present study, we sought to find structural features important for selectivity and specificity of ligand binding by the isotype δ. To this end, we determined the conditions of expression and purification of the protein hPPARδ LBD, as well as the appropriate conditions for maintaining it through the technique of circular dichroism. The oligomeric state of this receptor in solution was determined through the techniques of size exclusion chromatography and dynamic light scattering, which concluded that the protein is monomeric under the conditions tested. In addition, through a high-resolution structure of the protein hPPARδ LBD with the ligand GW 0742, we proposed the construction of two mutants, V312M and I328M, through which it was concluded that these two residues are potentially important for interaction of ligands structurally related to GW 0742 with the δ isotype. As there are few reports based on the complete structure of this receptor, and consequently about the influence of the N-terminal and DBD domains with the LBD domain, a brief study of the interaction between the nuclear receptor differential hPPARδ Full and three different cofactors in the presence of agonist and antagonist ligands were performed. For this, we determined the conditions of expression and purification of the protein hPPARδ Full, and using fluorescence anisotropy, it became clear that each cofactor has a different pattern of interaction with the protein which may be dependent on other regions of the protein in addition to those already described classically. This is a strong indication that different regions of hPPARδ can be key points in the regulatory process through cofactors.

No description available.

La maladie d'Alzheimer est la démence neurodégénérative la plus fréquente, en particulier chez les personnes âgées. A l'heure actuelle, aucun traitement ne permet d'arrêter efficacement le développement de la maladie. Le tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine (ANAVEX2-73) est un composé mixte avec une affinité modérée, de l'ordre du µM pour les récepteurs muscariniques et les récepteurs sigma-1. Des données préliminaires ont montré que la molécule avait des propriétés anti-amnésiantes et neuroprotectrices dans un modèle non transgénique de la maladie d'Alzheimer. L'objectif de cette thèse est de poursuivre le développement préclinique de la molécule. Nous avons montré, d'abord dans un modèle non-transgénique de la maladie d'Alzheimer, le modèle d'injection de peptide AB(25-35) oligomérisé chez la souris, que la molécule prévient l'hyperphosphorylation de la protéine Tau ainsi que la production du peptide AB(1-42), deux éléments clés de la physiopathologie de la maladie. Nous avons utilisé ce même modèle pour montrer que l'ANAVEX2-73 prévient les déficits de la fonction mitochondriale, qui sont présents de manière constante et précoce chez les patients. Enfin, nous avons montré qu'un traitement chronique de deux mois avec le composé, dans un modèle de souris transgéniques de la maladie, permet de restaurer les capacités cognitives chez les souris, de diminuer le stress oxydant et d'augmenter les marqueurs synaptiques. Cependant le traitement n'a pas permis de réduire la charge amyloïde dans le cerveau des souris. L'ensemble de ces résultats est encourageant pour le développement futur de la molécule, puisque cette dernière, en plus d'être neuroprotectrice et anti-amnésiante semble être efficace sur les éléments clés de la physiopathologie de la maladie. / Alzheimer's disease is the most common form of dementia in the elderly. There is however no efficient treatment to stop the disease progression. Tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmetanamine (ANAVEX2-73) is a mixed compound with moderate affinity for muscarinic and sigma-1 receptors. Preliminary data showed ANAVEX2-73 had anti-amnesic and neuroprotective poperties, in a non-transgenic model of Alzheimer's disease. The aim of this thesis is to improve knowledge about preclinical data of this molecule. We first showed that, in the non-transgenic AB(25-35) mouse model, ANAVEX2-73 prevented Tau protein hyperphosphorylation and AB(1-42) peptide seeding, two key parameters involved in Alzheimer's disease physiopathology. We also used this model tho show that ANAVEX2-73 prevented mitochondrial dysfunction, consistently reported as an early event of the disease in patients. The last part of this thesis showed that a two-month chronic treatment with ANAVEX2-73 in a transgenic mouse model of Alzheimer's disease reversed cognitive dysfunction and prevented loss of synaptic markers and increased of oxidative stress. However, we could not show a decrease of amyloid load in mouse brain after chronic treatment. Altogether, these results suggest that ANAVEX2-73 treatment could be effective to treat Alzheimer's disease. In addition to its neuroprotective and anti-amnesic property, it also prevents key hallmarks involved in the physiopathology of Alzheimer's disease.

Die vorliegende Arbeit beschäftigt sich mit der Synthese neuer heptadentater Liganden und deren Gd(III)- und Y(III)-Komplexen. Diese auf dem AAZTA-Grundgerüst basierenden Liganden sollten in 6-Position des Perhydro-1,4-diazepinrings über eine zusätzliche funktionelle Gruppe verfügen, wodurch eine kovalente Anbindung der entsprechenden Gd(III)-Komplexe an Makromoleküle, Polymere oder Peptide möglich wäre. Abschließend wurden die Protonen-Relaxivitäten der darge¬stellten Gd(III)-Komplexe bestimmt, und die Komplexe bezüglich ihrer Eignung als Kontrastmittel bei der MRI untersucht. / The present dissertation deals with the synthesis of new heptadentate ligands and their corresponding gadolinium and yttrium complexes. These ligands, based on the AAZTA framework, should bear an additional functional group in 6-position of the perhydro-1,4-diazepine ring to bind the respective Gd(III) complexes covalently to macromolecules, polymers or peptides. Finally the proton relaxivities of the synthesized Gd(III) complexes were determined in order to examine the complexes regarding their application as MRI contrast agents.

Diese Arbeit beschäftigte sich mit der Quantifizierung von Zelladhäsion vermittelnden Liganden in und auf dünnen Hydrogelschichten, die zur Oberflächenmodifizierung auf Biomaterialien aufgebracht wurden. Das bereits etablierte und gut charakterisierte inerte NCO-sP(EO-stat-PO) Hydrogelsystem, das eine einfache und reproduzierbare Bioaktivierung mit Peptiden erlaubt, wurde als Basis für diese Arbeit verwendet. Diese Hydrogele können auf zwei Weisen funktionalisiert werden. Liganden können entweder mit der Prepolymerlösung vor der Beschichtung gemischt (Einmischmethode) oder frische Hydrogelschichten mit einer Ligandenlösung inkubiert werden (Inkubationsmethode). Der erste Teil dieser in drei Hauptteile unterteilten Arbeit, beschäftigte sich mit der Konzentrationsbestimmung der Liganden in der gesamten Tiefe der Hydrogelschicht, während sich der zweite Teil auf die oberflächensensitive Quantifizierung von Zelladhäsion vermittelnden Molekülen an der biologischen Grenzfläche konzentrierte. Die Ergebnisse wurden mit Zelladhäsionskinetiken verglichen. Der dritte Teil dieser Arbeit beschäftigte sich mit der biochemischen als auch strukturellen Nachahmung der komplexen Extrazellulärmatrix (ECM). Das ECM Protein Fibronektin (FN) wurde über Zucker-Lektin Anbindung präsentiert und Zellverhalten auf diesen biomimetischen Oberflächen untersucht. Ebenfalls wurde Zellverhalten in einer dreidimensionalen Faserumgebung mit identischer Oberflächenchemie wie in den beiden ersten Teilen dieser Arbeit untersucht und mit der Peptidkonzentration korreliert. Insgesamt, war die Hauptfragestellung in dieser Arbeit ‘Wie viel?’, d.h. einerseits die Ermittlung der maximalen, als auch der für Zelladhäsion optimalen Ligandendichte. Im ersten praktischen Teil der vorliegenden Arbeit (Klassische Quantifizierung) wurden Liganden in der gesamten Hydrogelschicht, als auch speziell in oberen Bereichen der Schichten quantifiziert. Die Untersuchung der Hydrogelschichten in Wellplatten und auf Glas funktionalisiert mit GRGDS und 125I-YRGDS erfolgte in Kapitel 3 mittels Radioaktivmessung. Wurden Hydrogelschichten mittels Inkubationsmethode funktionalisiert, konnte eine Sättigung mit Liganden bei etwa 600 µg/mL ermittelt werden. Mittels Einmischmethode funktionalisierte Hydrogele erreichten keine maximale Ligandenkonzentration in den Schichten, mit dem Verhältnis 2/1 als maximales verwendetes Verhältnis. Höhere Liganden zu Prepolymer Verhältnisse als 2/1 wurden jedoch nicht verwendet, um eine ausreichende Vernetzung der Hydrogele nicht zu gefährden. Zur Detektion mittels Röntgenphotoelektronenspektroskopie (XPS) und Flugzeit-Sekundärionen-Massen-spektrometrie (TOF-SIMS) (Kapitel 4) wurden eine fluorierte Aminosäure und ein iodiertes Peptid mit den Prepolymeren in molaren Verhältnissen von 1/2, 1/1 und 2/1 gemischt. Beide Methoden ermittelten eine maximale Ligandenkonzentration bei Verhältnissen von 1/1. Zusätzliche Liganden (2/1) führten zu keiner vermehrten Anbindung. Wesentlich im Zusammenhang mit der Ligandenquantifizierung auf Biomaterialien ist, diese an der Oberfläche, die für Zellen zugänglich ist, durchzuführen. Im zweiten Teil dieser Arbeit (Oberflächensensitive Quantifizierung) kamen daher Methoden zum Einsatz, die Liganden ausschließlich auf der Oberfläche quantifizierten. Zur Detektion mit Oberflächenplasmon-resonanz (SPR) und akustischer Oberflächenwellentechnologie (SAW) in Kapitel 5 musste die Standardbeschichtung der Hydrogele von Glas und Silikon auf Cystamin funktionalisierte Goldoberflächen übertragen werden. Mittels Ellipsometrie und Rasterkraftmikroskopie (AFM) konnte nur eine dünne und inhomogene Hydrogelbeschichtung nachgewiesen werden. Dennoch zeigten SPR und SAW die Unterbindung von Serum und Streptavidin (SA) Adsorption auf nicht funktionalisierten Schichten, jedoch eine spezifische und konzentrationsabhängige SA Bindung auf Hydrogelschichten, die mit Biocytin und GRGDSK-biotin funktionalisiert wurden. Die Ligandenquantifizierung mittels Enzymgekoppeltem Immunadsorptionstest (ELISA) und Enzymgekoppelten Lektinadsorptionstest (ELLA) (Kapitel 6) wurde auf Hydrogelschichten in Wellplatten und auf Glas angewendet, die mit verschiedenen Liganden mittels Inkubation und Einmischung funktionalisiert wurden. Das Modellmolekül Biocytin, das biotinylierte Peptid GRGDSK-biotin, das ECM Protein Fibronektin (FN), als auch die Modellzucker N-Acetyl-glukosamin (GlcNAc) und N-Acetyllaktosamin (LacNAc) konnten spezifisch in verschiedenen Konzentrationen nachgewiesen werden. Beispielhaft seien hier Schichten auf Glas genannt, die mittels Einmischmethode mit GRGDSK-biotin funktionalisiert wurden, da diese zum Vergleich in Kapitel 8 herangezogen wurden. Auf diesen Oberflächen wurde eine maximale Peptidkonzentration auf der Oberfläche bei einem Peptid zu Prepolymer Verhältnis von 1/5 ermittelt. Neben diesen verschiedenen Quantifzierungsmethoden ist die in vitro Analyse mit Zellen nicht zu vernachlässigen (Kapitel 7). Hierzu wurden Hydrogele auf Glas aufgebracht und mit GRGDS mittels Einmischmethode funktionalisiert. Durch Zählen adhärenter primärer humaner dermaler Fibroblasten (HDF) auf Mikroskopbildern wurde eine maximale Zelladhäsion bei dem Peptid zu Prepolymer Verhältnis von 1/5 festgestellt. Hingegen wurde ein Verhältnis von 1/2 für optimale Zelladhäsion ermittelt, wenn Zellen zur Quantifizierung von den Hydrogelen abgelöst und im CASY® Zellzähler quantifiziert wurden. Zusätzlich wurde die Zellvitalität durch Messung intrazellulärer Enzymaktivitäten gemessen, jedoch konnte kein Zusammenhang zwischen Zellvitalität und GRGDS Konzentration hergestellt werden. Adhärente HDFs waren in allen Fällen vital, unabhängig von der Ligandenkonzentration auf der Oberfläche. Auch die Mausfibroblasten Zelllinie NIH L929 wurde auf Hydrogelen mit verschiedenen GRGDS zu Prepolymer Verhältnissen durch Zählen adhärenter Zellen auf Mikroskopbildern untersucht. Diese im Verhältnis zu HDFs wesentlich kleineren Mauszellen benötigten höhere GRGDS Konzentrationen (2/1) für maximale Zelladhäsion. Nach der Ligandenquantifizierung in Kapitel 3 bis 7, wurden diese Ergebnisse in Kapitel 8 miteinander verglichen. Hierzu wurden Messungen auf Hydrogelschichten verwendet, die mittels Einmischmethode funktionalisiert wurden. Während die Quantifizierung mittels Radioaktivmessung in der gesamten Tiefe der Hydrogelschichten keine maximale Ligandenkonzentration ermitteln konnte, war in den oberen Bereichen der Schicht ein Maximum an Liganden bei 1/1 festzustellen (XPS, TOF-SIMS). SPR und SAW wurden zum Vergleich nicht herangezogen, da die Beschichtung auf Gold erst optimiert werden muss. Oberflächensensitive Quantifizierung mittels ELISA und Zelladhäsion, die lediglich die sterisch zugänglichen Liganden auf einer Oberfläche nachweisen, ergaben übereinstimmend eine optimale Ligandenkonzentration für SA Bindung und Zelladhäsion bei einem Peptid zu Prepolymer Verhältnis von 1/5. Dies unterstreicht, wie wichtig der Vergleich der Methoden, als auch die Verwendung von oberflächensensitiven Methoden ist. Der dritten Teil dieser Arbeit beschäftigte sich mit der biochemischen und strukturellen Nachahmung der komplexen extrazellulären Umgebung (Advanced ECM engineering), ein wichtiger Aspekt in der Biomaterialforschung, da zum größten Teil zwei-dimensionale Biomaterialien zum Einsatz kommen, die direkt mit Liganden kovalent funktionalisiert werden. Die ECM ist jedoch um ein Vielfaches komplexer und die bestmögliche Nachahmung ist Voraussetzung für eine bessere Akzeptanz durch Zellen und Gewebe. In Kapitel 9 wurde eine Möglichkeit aufgezeigt, das ECM Protein FN nicht-kovalent über Zucker-Lektinbindungen zu immobilisieren. Ein Schichtaufbau von Hydrogel, dem darauf durch Mikrokontakt-druckverfahren (MCP) kovalent gebundenen Zucker Poly-N-Acetyllaktosamin (polyLacNAc) und den darauf nicht-kovalent gebundenen Galektin His6CGL2 und FN, konnte mit Fluoreszenzfärbung elegant nachgewiesen werden. Optimale Konzentrationen für den Schichtaufbau wurden mittels ELLA/ELISA auf Hydrogelschichten ermittelt, die durch Inkubation mit dem Zucker funktionalisiert wurden. Nur der komplette Schichtaufbau konnte zufriedenstellende HDF Adhäsion vermitteln und im Vergleich zu Zellkulturpolystyrol (TCPS) Oberflächen konnten HDFs auf dem biomimetischen Schichtaufbau schneller adhärieren und spreiten. Zudem wurde die Umorganisierung von auf Glas adsorbiertem FN, auf NCO-sP(EO-stat-PO) kovalent gebundenem FN und biomimetisch über polyLAcNAc-His6CGL2 gebundenem FN durch HDFs verglichen. Nur auf den biomimetischen Oberflächen schien eine Umorganisation durch die Zellen möglich, wie sie auch in der ECM zu finden ist. Diese biomimetische und flexible Präsentation eines Proteins erwies sich als vielversprechende Möglichkeit eine biomimetischere Oberfläche für Zellen zu schaffen, die eine optimale Biokompatibilität ermöglichen könnte. Auch die strukturelle Nachahmung der ECM ist eine vielversprechende Strategie zum Nachbau der ECM. In Kapitel 10 wurde ein Einschrittverfahren zur Herstellung synthetischer, bioaktiver und degradierbarer Faserkonstrukte durch Elektrospinnen zur Nachahmung der ECM präsentiert. In diesem System wurden durch Zugabe von NCO-sP(EO-stat-PO) als reaktives Additiv zu Poly(D,L-laktid-co-Glycolid) (PLGA) Fasern hergestellt, die mit einer ultradünnen, inerten Hydrogelschicht versehen waren. Es konnte gezeigt werden, dass durch die Verwendung von NCO-sP(EO-stat-PO) als Additiv die Adsorption von Rinderserumalbumin (BSA) im Vergleich zu PLGA um 99,2% reduziert, die Adhäsion von HDFs verhindert und die Adhäsion von humanen mesenchymalen Stammzellen (MSC) minimiert werden konnten. Spezifische Bioaktivierung wurde durch Zugabe von Peptidsequenzen zur Spinlösung erreicht, welche kovalent in die Hydrogelschicht eingebunden werden konnten und kontrollierte Zell-Faser Interaktionen ermöglichten, Um die spezifische Zelladhäsion an solchen inerten Fasern zu erzielen, wurde GRGDS kovalent auf der Faseroberfläche gebunden. Dies erfolgte durch Zugabe des Peptids zur Polymerlösung vor dem Elektrospinnen. Als Negativkontrolle wurde die Peptidsequenz GRGES an die Faseroberfläche gebunden, welche durch Zellen nicht erkannt wird. Während die Verhinderung unspezifischer Proteinadsorption für die Peptidmodifizierten Fasern erhalten blieb, konnten HDFs lediglich auf den mit GRGDS Peptid modifizierten Fasern adhärieren, proliferieren und nach zwei Wochen eine konfluente Zellschicht aus vitalen Zellen bilden. Zusätzlich konnten MSCs auf GRGDS funktionalisierten Fasern adhärieren. Liganden konnten auf Fasern quantifiziert werden, indem die ELISA Technik aus Kapitel 6 auf Faseroberflächen transferiert wurde. Um das Potential der biochemischen und strukturellen Nachbildung der ECM aufzuzeigen, wurden beide Ansätze miteinander kombiniert. Die Immobilisierung von polyLacNAc auf die Hydrogelfasern durch Inkubation und der Schichtaufbau mit His6CGL2 und FN resultierte in HDF Adhäsion. / This thesis concerned the quantification of cell adhesion molecules (CAM) in and on thin hydrogel films as surface modification of biomaterials. The established and well characterized, per se inert NCO-sP(EO-stat-PO) hydrogel system which allows the easy and reproducible bioactivation with peptides was used as basis for this thesis. Two methods can be used to functionalize the coatings. Ligands can either be mixed into the prepolymer solution in prior to layer formation (mix-in method), or freshly prepared coatings can be incubated with ligand solution (incubation method). Divided into three major parts, the first part of the thesis dealt with the concentration of ligands in the bulk hydrogel, whereas the second part of the thesis focused on the surface sensitive quantification of CAMs at the biointerface. The results were correlated with cell adhesion kinetics. The third part of this thesis investigated the biochemical and the structural mimicry of the extracellular matrix (ECM). ECM proteins were presented via sugar-lectin mediated binding and cell behavior on these surfaces was analyzed. Cell behavior on three-dimensional fibers with identical surface chemistry as the coatings in the previous sections of the thesis was analyzed and correlated with the amount of peptide used for bioactivation. Overall, the main question of this work was ‘How much?’ regarding maximal as well as optimal ligand concentrations for controlled cell-hydrogel interactions. The focus in the first practical part of this thesis was to analyze the amount of ligands in NCO-sP(EO-stat-PO) hydrogels using classical quantification methods. Coatings in 96-well plates as well as on glass were functionalized with GRGDS and 125I-YRGDS for radioisotopic detection (Chapter 3). Using the incubation method for functionalization, a maximal ligand binding using peptide concentrations of 600 µg/mL could be determined. When functionalization was introduced via the mix-in method, a clear tendency for higher ligand concentrations with increasing ligand to prepolymer ratio was observed, but no maximal ligand binding could be detected with a ligand to prepolymer ratio of 2/1 being the highest ratio investigated. This ratio of 2/1 was not exceeded to ensure that complete crosslinking of the hydrogel was not affected. In Chapter 4, a fluorinated amino acid and an iodinated peptide were immobilized to the hydrogels using the mix-in method and were detected by X-ray photoelectron spectroscopy (XPS) and time-of-flight secondary ion mass spectrometry (TOF-SIMS). In these measurements, maximal ligand binding was detected for a ligand to prepolymer ratio of 1/1. Higher ligand to prepolymer ratios did not result in any significant increase in ligand concentrations in the surface near regions of the crosslinked hydrogels. To address the question of how many ligands were actually accessible for cell interaction at the interface, surface sensitive quantification methods were applied in the second part of this thesis. For the quantification with surface plasmon resonance (SPR) and surface acoustic wave technology (SAW) (Chapter 5), the hydrogel coating procedure needed to be transferred onto cystamine functionalized gold surfaces. Characterization with ellipsometry and atomic force microscopy (AFM) revealed inhomogeneous cystamine binding to the activated surfaces, which resulted in inhomogeneous coatings. Nevertheless, it could be shown that SPR as well as SAW were suitable methods for the surface sensitive quantification of the ligand concentration on NCO-sP(EO-stat-PO) hydrogels. Non-functionalized coatings resisted non-specific serum as well as streptavidin (SA) adsorption. Coatings functionalized with biocytin and GRGDSK-biotin introduced specific SA binding that was dependent on the biotin concentration at the surface. Additionally, enzyme linked immunosorbent assay (ELISA) and enzyme linked lectin assay (ELLA) (Chapter 6) were applied to coatings in 96-well plates and on glass. Coatings were functionalized with the model molecule biocytin, the biotinylated peptide GRGDSK-biotin, the ECM protein fibronectin (FN), as well as the carbohydrates N-acetylglucosamine (GlcNAc) and N-acetyllactosamine (LacNAc). All ligands could be successfully detected with antibodies or SA via ELISA or ELLA. Maximal GRGDSK-biotin binding to the hydrogel coatings on glass was achieved at a peptide to prepolymer ratio of 1/5, which was used as reference value in Chapter 8. Last but not least, cell adhesion (Chapter 7) was quantified depending on the GRGDS concentration on hydrogel coatings on glass. Maximal adhesion of primary human dermal fibroblast (HDF) was observed at GRGDS to prepolymer ratios of 1/5, when adherent cells were counted on life cell images. Quantification of adherent cells using the CASY® cell counter revealed maximal HDF adhesion at molar ligand to prepolymer ratios of 1/2. However, cell vitality detected by intracellular enzyme activities was not dependent on the GRGDS concentration. Cells which managed to adhere were vital regardless of the amount of ligands present. Additionally, adhesion of fibroblasts from the murine cell line NIH L929 was analyzed by counting on life cell images. These cells, being much smaller than the HDF cells, needed higher GRGDS to prepolymer ratios (2/1) for proper cell adhesion. All quantification methods applied to analyze hydrogels which were functionalized by the mix-in method in Chapter 3, 4, 6 and 7, were compared in Chapter 8. Radiodetection gave information about the ligand concentrations throughout the whole hydrogel and no maximal amount of ligands could be detected when increasing the peptide to prepolymer ratio. In contrast, XPS and TOF-SIMS which only penetrated the surface near regions of the coating, a maximal ligand binding to the hydrogel was detected for 1/1 ratios. SPR and SAW were not included in this comparison, as the coatings on gold need to be optimized first. The two surface sensitive quantification methods (ELISA and HDF adhesion) could give information about the quantity of peptide which was sterically available for SA or cell binding. With these methods, maximal SA and cell binding was detected at ratios of 1/5. These results underline the importance of carefully compare the different methods. Beside ligand quantification on hydrogels, the third part of this thesis was concerned with the biochemical and structural mimicry of the ECM by advanced ECM engineering to design biomimetic biomaterials that are better accepted by cells and tissue. The subject of Chapter 9 was the biomimetic and flexible presentation of the ECM protein FN. FN was attached via sugar-lectin mediated binding to NCO-sP(EO-stat-PO) hydrogels. The build-up of the covalently immobilized sugar poly-N-acetyllactosamine (polyLacNAc), the subsequent non-covalent binding of the fungal galectin His6CGL2, and FN could be elegantly proven by fluorescent staining on coatings which were functionalized with the sugar by micro contact printing (MCP). Further experiments were carried out on build-ups, where polyLacNAc was immobilized on the hydrogel by incubation. Optimal parameters for the layer build-up were determined by ELLA/ELISA. Only the complete build-up induced proper adhesion of HDFs. Compared to tissue culture polystyrene (TCPS), cells adhered and spread faster on the biomimetic surfaces. The flexible presentation of FN allowed HDFs to rearrange homogenously immobilized FN into fibrillar structures, which seemed not to be possible when FN was adsorbed on glass or covalently bound directly to the hydrogel coatings. This new approach of a flexible and biomimetic presentation of an ECM protein allows new ways to design biomaterials with best possible cell-material interactions. The work described in Chapter 10 focused on the structural mimicry of the fibrous ECM structures by electrospinning of synthetic, bioactive, and degradable fibers. Poly(D,L-lactide-co-glycolide) (PLGA) and NCO-sP(EO-stat-PO) were electrospun out of one solution in an easy one-step preparation resulting in fibers with an ultrathin inert hydrogel layer at the surface. By adding GRGDS to the solution prior to electrospinning, specifically interacting fibers could be obtained. In comparison to PLGA, the adsorption of bovine serum albumin (BSA) could be reduced by 99.2%. As a control, the non-active peptide GRGES was immobilized to the fiber. These fibers did not allow cell adhesion, showing that the integrity of the hydrogel coated fibers was not affected by the immobilization of peptides. HDF adhesion was obtained by functionalization with GRGDS, leading to the adhesion, spreading, and proliferation of HDFs. Also mesenchymal stem cells (MSC) could adhere to GRGDS functionalized fibers. Additionally, for ligand quantification, the ELISA technique was successfully transferred to fiber substrates. To highlight the potential of the approaches for the biochemical and structural mimicry of the ECM, the sugar polyLacNAc was immobilized on the PLGA/sP(EO-stat-PO) fibers followed by the subsequent layer build-up with His6CGL2 and FN. These fibers triggered HDF adhesion.